Pneumococcal vaccines for older adults: getting the timing right
Campos-Outcalt, D.
Journal of Family Practice 63(12): 730-733
2014
ISSN/ISBN: 1533-7294 PMID: 25486320 Document Number: 675647
Document emailed within 1 workday
Related Documents
Vyse, A.; Campling, J.; Czudek, C.; Ellsbury, G.; Slack, M. 2020: The proportion of contemporary invasive pneumococcal disease and pneumococcal pneumonia in UK adults reflected by serotypes included in the 13-valent pneumococcal conjugate vaccine and next generation higher valency pneumococcal conjugate vaccines in development Vaccine 38(51): 8068-8070Muruganathan, A. 2015: Addressing the Remaining Challenge of Pneumococcal Disease in Older Adults Journal of the Association of Physicians of India 63(4 Suppl): 6
Ayala-Montiel, O.; Mascareñas de los Santos, César.; García-Hernández, D.; Rendón-Muñiz, J.; García-Olvera, L. 2004: Reactogenicity of the simultaneous administration of influenza and pneumococcal vaccines in adults over 55 years of age Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion 56(1): 27-31
Hak, E.; Grobbee, D.E.; Sanders, E.A.M.; Verheij, T.J.M.; Bolkenbaas, M.; Huijts, S.M.; Gruber, W.C.; Tansey, S.; McDonough, A.; Thoma, B.; Patterson, S.; van Alphen, A.J.; Bonten, M.J.M. 2008: Rationale and design of CAPITA: a RCT of 13-valent conjugated pneumococcal vaccine efficacy among older adults Netherlands Journal of Medicine 66(9): 378-383
Feikin, D.R.; Jagero, G.; Aura, B.; Bigogo, G.M.; Oundo, J.; Beall, B.W.; Karani, A.; Morpeth, S.; Njenga, M.K.; Breiman, R.F. 2010: High rate of pneumococcal bacteremia in a prospective cohort of older children and adults in an area of high HIV prevalence in rural western Kenya Bmc Infectious Diseases 10: 186
Libwea, J.N.; Kobela, M.; Ollgren, J.; Emah, I.; Tchio, R.; Nohynek, H. 2014: Predictors to parental knowledge about childhood immunisation/EPi vaccines in two health districts in Cameroon prior to the introduction of 13-valent Pneumococcal Conjugate Vaccines (PCV-13) Pan African Medical Journal 17: 187
Kaphengst, K.J. 2005: Best timing of pneumococcal revaccination in COPD Postgraduate Medicine 118(2): 3; Discussion 3
Hilleman, M.R.; McLean, A.A.; Vella, P.P.; Weibel, R.E.; Woodhour, A.F. 1979: Pneumococcal vaccines Pathologie-Biologie 27(9): 579-588
Vernacchio, L.; Neufeld, E.J.; Macdonald, K.; Kurth, S.; Murakami, S.; Hohne, C.; King, M.; Molrine, D. 1998: Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell disease Journal of Pediatrics 133(2): 275-278
Mulholland, E.K. 2000: Conjugate pneumococcal vaccines: an overview Medical Journal of Australia 173(S2): S48-S50
Galiza, E.P.; Heath, P.T. 2007: Pneumococcal conjugate vaccines. A review Minerva Medica 98(2): 131-143
2013: 13-valent pneumococcal vaccine: 50 years of age and older Prescrire International 22(135): 38
Lyu, Y.B.; Zhou, J.H.; Duan, J.; Wang, J.N.; Shi, W.Y.; Yin, Z.X.; Shi, W.H.; Mao, C.; Shi, X.M. 2019: Association of plasma albumin and hypersensitive C-reactive protein with 5-year all-cause mortality among Chinese older adults aged 65 and older from 8 longevity areas in China Zhonghua Yu Fang Yi Xue Za Zhi 53(6): 590-596
Siegrist, C-Anne. 2011: Swiss vaccinology update: new glycoconjugate vaccines against pneumococcal and meningococcal infections Revue Medicale Suisse 7(278): 154-158
Wongsawat, J.; Chokephaibulkit, K. 2010: Implication of pneumococcal conjugate vaccines to public health: Thailand perspective Journal of the Medical Association of Thailand 93(Suppl 5): S53-S60
Bakır, M.; Türel, O.; Topachevskyi, O. 2012: Cost-effectiveness of new pneumococcal conjugate vaccines in Turkey: a decision analytical model Bmc Health Services Research 12: 386
Scott, J.A.G.; English, M. 2008: What are the implications for childhood pneumonia of successfully introducing Hib and pneumococcal vaccines in developing countries? Plos Medicine 5(4): E86
Mezones-Holguín, E.; Bolaños-Díaz, R.; Fiestas, Víctor.; Sanabria, César.; Gutiérrez-Aguado, A.; Fiestas, Fán.; Suárez, Víctor.J.; Rodriguez-Morales, A.J.; Hernández, Aán.V. 2014: Cost-effectiveness analysis of pneumococcal conjugate vaccines in preventing pneumonia in Peruvian children Journal of Infection in Developing Countries 8(12): 1552-1562
Urun, Y.; Akbulut, H.; Demirkazik, A.; Cay Senler, F.; Utkan, G.; Onur, H.; Icli, F. 2013: Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members Journal of BUON: Official Journal of the Balkan Union of Oncology 18(2): 511-515
Auld, A.F.; Agolory, S.G.; Shiraishi, R.W.; Wabwire-Mangen, F.; Kwesigabo, G.; Mulenga, M.; Hachizovu, S.; Asadu, E.; Tuho, M.Zanga.; Ettiegne-Traore, V.; Mbofana, F.; Okello, V.; Azih, C.; Denison, J.A.; Tsui, S.; Koole, O.; Kamiru, H.; Nuwagaba-Biribonwoha, H.; Alfredo, C.; Jobarteh, K.; Odafe, S.; Onotu, D.; Ekra, K.A.; Kouakou, J.S.; Ehrenkranz, P.; Bicego, G.; Torpey, K.; Mukadi, Y.Diul.; van Praag, E.; Menten, J.; Mastro, T.; Dukes Hamilton, C.; Swaminathan, M.; Dokubo, E.Kainne.; Baughman, A.L.; Spira, T.; Colebunders, R.; Bangsberg, D.; Marlink, R 2014: Antiretroviral therapy enrollment characteristics and outcomes among HIV-infected adolescents and young adults compared with older adults--seven African countries, 2004-2013 MMWR. Morbidity and mortality weekly report 63(47): 1097-1103